A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit (RW)

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

The ReWalk enables people with lower limb disabilities to carry out routine ambulatory functions (stand, walk, climb stairs etc.). It can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other severe walking impairments. The device promises to restore the dignity of disabled persons, enabling them to work and improve their general health and quality of life, as well as significantly reduce medical and other related expenses.

Condition or disease	Intervention/treatment	Phase
Paraplegia; SCI	Device: ReWalk - a motorized exoskeleton suit	Not Applicable

Detailed Description:

The ReWalk comprises light wearable brace support suit, which integrates DC motors at the joints, rechargeable batteries, an array of sensors and a computer-based control system. It is snugly fitted on the body and worn underneath the clothing, if desired. ReWalk is a new realization of the Powered Exoskeleton concept, first tried about fifty years ago with no success. Employing an innovative, non-robotic design approach, it uniquely matches the user's capabilities with the control mechanisms. Upper-body movements of the user are detected and used to initiate and maintain walking processes. User stability and safety during ambulation is secured by concurrent use of safety aids such as crutches for walking and railing for stairs.

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	6 participants
Intervention Model:	Single Group Assignment
Masking:	None (Open Label)
Primary Purpose:	Supportive Care
Official Title:	Study of the ReWalk Motorized Exoskeleton Suit That Enables Individuals With Lower Limbs Impairment to Walk and to Perform Other Basic Mobility Functions.
Study Start Date :	February 2008
Actual Primary Completion Date :	January 2009
Actual Study Completion Date :	January 2009

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm	Intervention/treatment
Experimental: A; A group of paraplegics.	Device: ReWalk - a motorized exoskeleton suit; The subject will wear the ReWalk suit and have training sessions for walking with the device.; Other Name: Exoskeleton suit

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Observation and subject feedback [ Time Frame: 3 months ]

Secondary Outcome Measures :

1. subject tolerance [ Time Frame: 3 months ]

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years to 55 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Chronic (at least 6 months after injury) complete cervical(C7-8) or thoracic (T1-T12) spinal cord injury
• Age between 18-55
• Male and non-pregnant non-lactating female
• Regular use of RGO or bing able to stand up using a device (e.g. EasyStand)
• under 100 kg and between 155-200 cm of height

Exclusion Criteria:

• History of severe neurological injuries other than SCI (MS, CP, ALS, TBI etc)
• Severe concurrent medical diseases: infections, heart or lung, pressure sores
• Unstable spine or unhealed limbs or pelvic fractures
• Psychiatric or cognitive situations that may interfere with the study

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

Israel
Sheba Medical Center, Neurological Rehabilitation Department
Tel-Hashomer, Israel, 52621

Sponsors and Collaborators

ReWalk Robotics, Inc.

Investigators

Principal Investigator:	Gabi Zeilig, MD	Sheba Medical Center

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	Dr. Gabi Zeilig, Head of the Neurological Rehabilitation Department (PI), Sheba Medical center
ClinicalTrials.gov Identifier:	NCT00627107 History of Changes
Other Study ID Numbers:	RW-002
First Posted:	February 29, 2008
Last Update Posted:	November 30, 2010
Last Verified:	November 2010

Keywords provided by ReWalk Robotics, Inc.:

ReWalk, Paraplegia, SCI

Additional relevant MeSH terms:

Paraplegia; Paralysis; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms